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ABSTRACT 
Nanostructured Porous Silicon Scaffolds for  
Enhanced Biocompatibility of Multichannel Microelectrodes 
Stefanie Joy Hallman 
Karen Moxon, Ph.D. 
 
 
 
Many different types of microelectrodes have been developed for use as a direct 
Brain-Machine Interface (BMI) to chronically record single- neuron action potentials 
from ensembles of neurons and control an effector.  For example, a BMI device designed 
for human quadriplegic patients successfully used single neuron activity to move a cursor 
on a computer screen.  However, these devices eventually failed. This failure was not due 
to failure of the microelectrodes, but more likely due to damage to surrounding tissue that 
results in the formation of a non-conductive glial scar.   
 The use of nanostructured microelectrode surfaces to mimic the extracellular 
environment has been previously shown in vitro to positively affect neural survival and 
decrease glial cell proliferation. In this thesis, we tested whether nanostructured porous 
silicon would reduce glial activation around the microelectrode compared to smooth 
silicon.  To accomplish this, we first designed a semi-automated process to quantify 
immunological staining around the microelectrode hole.   We then examined the effect of 
implanting different surfaces for 1, 2, 4 and 6 weeks.  Our immunohistochemical 
quantification process showed that porous surfaces decreased astrocytic up-regulation 
around the microelectrode insertion site, including less hypertrophied astrocytic cell 
bodies. Additionally, survival of neurons increased and recruitment of macrophages was 
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decreased at one week post-insertion. Therefore, nanostructured porous silicon is more 
compatible with the brain environment than smooth silicon.  
 In the long term, we hope that implementation of a nanostructured microelectrode 
surface will lead to a sustainable, chronically implantable microelectrode that can record 
from every recording site indefinitely. Once this goal has been achieved, BMI devices 
will be viable alternatives to patients who have lost normal motor function.  
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1. INTRODUCTION 
 
In the past few decades, recording microelectrodes have been utilized to obtain 
electrical information directly from neurons to quantify brain activity. Many different 
types of these recording microelectrodes have been developed for this purpose. The 
implementation of recording microelectrodes in the human brain holds great promise for 
therapeutic treatments as well as the interface for a direct Brain-Machine Interface (BMI) 
(Nicolelis et al., 2003). This interface could restore some level of voluntary interactions 
for severely paralyzed patients through the manipulation of an external effector, such as a 
cursor on a computer screen (Hochberg et al., 2006). Although there are less invasive 
methods for moving a cursor on a screen, the ability to record from populations of single 
neurons has the potential to allow for finer controls. The existing methods of using eye 
gaze or electroencephalography (EEG) recordings do not provide as many degrees of 
freedom for effector control and require all of the individual’s attention. For example, the 
eye gaze methodology requires that the patient look only at the sensing device throughout 
its use. Implantable BMI technology has the promise to provide an avenue for 
reconnecting motor areas of the brain to an external effector for use that is more 
‘unobtrusive’ (Hochberg et al., 2006).  However, all in vivo human applications 
involving the use of recording microelectrodes require the ability to chronically record 
action potentials from ensembles of single neurons indefinitely (Suner et al., 2005). 
Unfortunately, long term and sustainable use of recording microelectrodes has not 
been realized. This failure is hypothesized to be due not to the electrical failure of the 
devices but instead due to the biological response elicited by the insertion of the 
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microelectrode. Current studies show loss of discriminable single unit action potentials 
on the order of days, weeks, or in rare studies, months (Szarowski et al., 2003). For most 
microelectrode types, the loss of these recordings is not due to failure of the 
microelectrodes but more likely due to damage to surrounding tissue that results in the 
formation of non-conductive glial-scar.  In this way, the loss of discriminable action 
potentials is the direct result of the formation of the non-conductive glial scar, or sheath, 
which electrically isolates the microelectrode from the surrounding tissue.  
Our hypothesis is that one aspect of the microelectrode surface that is 
incompatible with the brain environment is the smooth surface of the implanted 
microelectrode shaft. Although many biological implants are made smooth to elicit less 
of a foreign body response, neural tissue is itself nanostructured and therefore this smooth 
surface many appear more unusual to the brain environment. Since the neural tissue is 
comprised of many elements that create nanostructured surfaces, such as the microtubule 
support of the cells in the brain, we propose it is best to implant microelectrode surfaces 
with nanostructure. The use of nanostructured microelectrode surfaces to mimic the 
extracellular environment has been shown to positively affect neural survival and 
decrease glial cell proliferation in vitro (Moxon et al., 2004). This thesis will quantify the 
affects of nanostructured surfaces to improve microelectrode biocompatibility in vivo.  
 In the long term, we hope that the implementation of nanostructured 
microelectrode surfaces will lead to a sustainable, chronically implantable microelectrode 
that can record from every recording site indefinitely.  
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2. SPECIFIC AIMS 
 
 
Specific Aim 1: Design a method to quantify the effects of microelectrode insertion on 
neuronal tissue.   
 
Specific Aim 2: Quantify the effect of porous silicon surfaces on biocompatibility of 
microelectrodes in vivo.  
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3. BACKGROUND INFORMATION 
 
While there is significant information on the brain’s response to traumatic brain 
injury, much less is understood about the immunological and cellular response to 
insertion of a microelectrode and, more importantly, how this response interferes with 
single neuron recording.  However, this response is complicated and involves many 
interrelated processes. Therefore, the brain’s reaction to the microelectrode is most likely 
a combination of the body’s general immunological response (Ludwig et al., 2006), the 
specific foreign body response (Anderson, Rodriquez, and Chang, 2008), and the trauma 
of microelectrode insertion (Zhong and Bellamkonda, 2005); each possibly involving the 
same cell types via different cellular pathways. 
There are two major pathologic states induced by the chronic implantation of 
arrays of microelectrodes into the brain (Moxon, 1999).  The first is a result of the action 
of inserting the microelectrode. When inserted, the microelectrode passes through the 
tissue and will damage and tear neuronal and glial processes, thus exposing the 
extracellular environment to intracellular proteins (Schultz and Willey, 1976).  In 
addition, even if one is careful to miss surface blood vessels, complete insertion of the 
microelectrode is likely to tear small capillaries, thus damaging the blood brain barrier 
(BBB) and exposing the extracellular environment of the brain to blood proteins 
(Schwartz et al., 2006).  The exposure of the extracellular environment to both 
intracellular and blood proteins initiates a cascade of events that can help to remove the 
damaged tissue and debris and heal the tissue or, if the damage is severe, create a glial 
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scar that electrically isolates the microelectrode and prevents it from recording single 
neurons. 
The second major effect arises from the continued presence of the microelectrode 
in the neural tissue, commonly referred to as the foreign-body response (Anderson, 
Rodriguez, and Chang, 2008).  If the brain is subject to a stab wound with a device about 
the size of a microelectrode, within six months, it will be difficult to identify the location 
of the wound if the procedure was completed under sterile conditions. The definition of a 
stab wound, in this instance, is that a device is inserted, then withdrawn, then the dura 
and skull are replaced over the stab site. However, if the device used to create the stab 
wound is left in place, a glial scar will form around the device, effectively walling it off 
from the healthy neural tissue (Liu et al., 1999). 
Understanding the biological response to microelectrode insertion is important as the 
biocompatibility of the microelectrode is directly related to the cellular response of the 
brain to microelectrode insertion.  
To address the issues surrounding the brain’s response to microelectrodes, it is 
first important to understand the different types of cells involved in the immunological 
response and how this response is naturally regulated.  Because this is such an important 
issue for recording from single neurons, the attempts to minimize this cellular response 
after microelectrode insertion will also be described.  Finally, the challenges of 
quantifying this response will be introduced through the description of recently 
developed methods to quantitatively measure the cellular response as a method to better 
target approaches that mitigate the adverse effects of the response on single neuron 
recording. 
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The Cellular Response 
 
There are three main cell types directly involved in the brain’s response to injury: 
microglia, macrophages, and astrocytes—collectively referred to as glia (Fawcett and 
Asher, 1999). In the event of injury, each of these cell types are up-regulated into their 
activated state (Seymour and Kipke, 2007). This transformation includes physical 
changes to cell morphology, expression of different surface proteins that act as signals to 
other cells, and changes in release of neurotrophic factors (Elkabes, DiCicco-Bloom, and 
Black, 1996).  Damage to neurons, glia, and the BBB initiate this transformation. All 
three types of cells will be discussed, with special emphasis on their activation process 
and contribution to the glial scar, the formation of which is likely the primary reason for 
loss of single neuron recordings. Figure 1 shows a representation of staining specific to 
these cell types. Two comprehensive reviews: Anderson, Rodriguez, and Chang  (2008) 
and Polikov et al. (2005) are in literature and provide a detailed description of the cellular 
mechanisms of this response.  
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Figure 1: Histological Representation of Astrocytes, Microglia, and Macrophages 
This figure is a colorized image depicting the cellular reaction to electrode insertion. 
Astrocytes are shown in green and macrophages are shown in red. This image was 
captured at a magnification of 10x.   
 
 
Microglia are the first of the three cells to become activated in the event of an 
injury. 5-10% of all glial cells found in the healthy brain are microglia (Ling, 1981). 
Under healthy brain conditions, the microglia  have long, thin processes that are highly 
branched. In the healthy brain, microglia are the primary defense against pathogens and 
constitute the initial immune response in the brain. One way microglia destroy foreign 
pathogens is through the use of cytotoxicity. Additionally, these cells are able to utilize 
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proteolytic enzymes to dissolve cellular debris. Once dissolved, the remnants can be 
removed via a variety of processes including phagocytosis (Streit, 1995; Purves et al., 
2001).   Therefore, microglia serve an important function in the brain. 
In response to a traumatic injury to the brain, microglia are activated within 24 
hours of the time of injury (Raivich et al., 1997).  Intracelluar debris released from 
damaged cells or blood released from damage to the blood brain barrier triggers 
microglia to express signals that attract other microglia to migrate to the site of the injury 
(Elkabes, DiCicco-Bloom, and Black, 1996). These signals also induce proliferation of 
the microglia surrounding the injury. In this activated state, the microglia morphology 
changes: the size of the cell body is increased, branching of the processes is reduced, and 
there is a marked thickening of the distal processes. This results in an ‘ameboid’ 
morphology (Giulian et al., 1986).   
Activated microglia have both beneficial and detrimental effects for the injured 
brain; often working through the same cellular signaling mechanisms.   For example, one 
benefit of the activated state to the injured brain is the increased secretion of neurotrophic 
factors and cytokines by the microglia in order to promote neuronal survival (Elkabes, 
DiCicco-Bloom, and Black, 1996). There are several important neurotrophic factors that 
are functionally and structurally related including nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) (Wiesmann and  de Vos, 
2001). These neurotrophins have positive effects on axonal growth and are involved in 
the development and maintenance of neurons (Moore et al., 2006). Direct secretion of 
NGF and BDNF by cultured microglia has been demonstrated in vitro (Elkabes, DiCicco-
Bloom, and Black, 1996). 
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 Activated microglia secrete cytokines that directly and indirectly regulate the 
production and release of neurotrophic factors, which can further benefit neuronal 
survival.  For example, activated microglia secrete interleukin-1 (IL-1) and tumor 
necrosis factor alpha (TNF-α). IL-1 induces astrocytes to release NGF (Woodroofe et al., 
1991) and TNF-α, which is also involved in the production of interleukin-10 (IL-10). 
Through different pathways, IL-10 is inhibitory for the production of TNF-α or produces 
a positive feedback loop that increases the production of TNF-α (Sheng et al., 1995).   
This same relationship is observed between IL-6 and NGF (Kossmann et al., 1995).  
Additionally, the activation of microglia is observed to precede asytrocyte activation and 
therefore the signaling pathways both these two cell types are interrelated and possibly 
causal (Babcock et al., 2003). Overall, microglia are involved in initiating a complex 
chemical signaling cascade that can increase the production of neurotrophic factors 
through regulation of cytokines and their influence on astrocytes. 
Through these same mechanisms, the activated microglia can have detrimental 
effects on neuronal survival because of the damage elicited from inflammation and high 
concentrations of neurotropic factors. Microglia are a potent source of monocyte chemo-
attractant protein (MCP-1): a chemokine. MCP-1 molecules recruit macrophages and 
activate microglia creating an inflammatory state. In addition, cytokines, such as IL-1, 
released by microglia can contribute to the inflammatory state by stimulating astrocytes 
to become reactive (Giulian et al., 1994).  In addition, both microglia and TNF-α can 
stimulate production of nitric oxide (NO) (Sheng et al., 1995) which has a cytotoxic 
effect on neurons.(Minghetti and Levi, 1998; Fitch and Silver, 1997).  These studies 
suggest that the same mechanisms that can aid in the repair of neural tissue, can, if 
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damage is severe, create an inflammatory state that further damages nearby, otherwise 
healthy, neurons. 
Some activation of microglia following microelectrode insertion is clearly 
beneficial to clear debris from torn and damaged neurons and secrete neurotrophins to aid 
in the survival of local cells damaged by microelectrode insertion (Nakajima et al., 2001).  
However, excessive damage to brain tissue induces over-proliferation of microglia and 
their signaling molecules, leading to inflammation and subsequent cell death.  When 
considering the insertion of microelectrodes, the damage of insertion accompanied by the 
continued presence of the microelectrode shaft is likely to be sufficient enough to lead to 
excessive activation of microglia.  The optimal situation would be to allow for some 
activation of microglia, sufficient to induce their beneficial effects, without 
overproduction, inflammation, and excessive damage.  Unfortunately, little is known 
about where the effects of microglia shift from being beneficial to detrimental and it is 
likely this threshold exhibits biological fluctuations depending on many variable 
biological factors.  Therefore, microglia will require more intensive study to be better 
understood, and eventually manipulated, to aid in the long term success of chronically 
implanted microelectrodes.  
The next cell type involved in the brain’s response to the microelectrode insertion 
is the macrophage. Macrophages are not normally found in neural tissue but exist within 
the vascular system. When blood vessels within the brain are severed, monocytes from 
the blood are recruited into the neural tissue via the break in the BBB and are induced 
into morphological changes to become macrophages (Fitch and Silver, 1997). Other 
components located within the vascular system, such as the complement system, also are 
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indicated to respond to the break in the BBB but discussion of these immunological 
compounds is beyond the scope of this report (Hortbit, 2004). It is important to note that 
although their origins are different, the up-regulated microglia inherent to the brain and 
the macrophages recruited through this break are morphologically indistinguishable.  
The effects of macrophages are confounding following microelectrode insertion. 
This is because their presence is necessary following severe damage in order to scavenge 
extensive cellular debris but their presence can also induce inflammation which further 
damages neurons and further induces cascades that increase the up-regulation of 
microglia (as discussed above) and astrocytes (as will be discussed below).   
Similar to microglia, macrophages are responsible for dissolving cellular debris 
by secreting protolytic enzymes and removing the debris via phagocytotsis (Fitch et al., 
1999; Biran et al., 2005). They also fuse together to form foreign body giant cells, which 
causes extreme inflammation (McNally and Anderson, 2002). This excessive 
inflammation due the foreign body giant cells can lead to cavitations at the site of a gross 
injury (Fitch et al., 1999).  Staining specific to macrophages and microglia is shown in 
Figure 2.  
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Figure 2: Microglia and Macrophages Surrounding Microelectrode Insertion 
This figure shows the histological identification of microglia and macrophages 
surrounding the microelectrode track. This image was captured at a magnification of 10x.   
 
 
 
Similar to the conclusion regarding microglia, since insertion of a microelectrode 
must damage the BBB, some proliferation of macrophages to clean up the damage is 
necessary.  However, this proliferation must be managed and eventually down-regulated 
to allow the microelectrodes to remain in contact with healthy neurons for long-term, 
chronic recording.  
The final important cell type in the brain’s response to microelectrode insertion is 
the astrocyte. Astrocytes constitute 30-65% of glial cells found in the healthy brain 
(Nathaniel and Nathaniel, 1981). In the healthy brain, astrocytes have many widespread 
cellular processes and perform multiple beneficial functions. Astrocytes provide 
mechanical support to neurons throughout their lifespan and provide growth cues to 
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developing neurons. Astrocytes also assist the transfer of nutrients across the BBB and 
take part in regulating the chemical environment required for healthy neuronal function 
(Araque et al., 1999). Astrocytes in the healthy state are shown in Figure 3.  
 
 
 
Figure 3: Astrocytes in the Healthy Brain 
This figure shows the histological identification of astrocytes in the healthy brain. This 
image was captured at a magnification of 10x.  
 
 
 
Activation of astrocytes takes place within the first week of injury—in this case 
microelectrode insertion. Immediately after activation, the astrocytes proliferate and 
migrate to the site of injury (Landis, 1994; Raivich et al., 1997). In this state, astrocytes 
are also known as reactive astrocytes (Klaver and Caplan, 2007). A visual representation 
of astrocytic up-regulation is shown in Figure 4.  
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Figure 4: Astrocytes Surrounding Microelectrode Insertion 
This figure shows the histological identification of astrocytes surrounding the 
microelectrode track. This image was captured at a magnification of 10x.   
 
 
The primary beneficial effect of reactive astrocytes is to aid in the production of 
NGF, which helps repair damaged neurons (Goss et al., 1998). However, reactive 
astrocytes have numerous detrimental effects to full tissue recovery which can interfere 
with the ability of microelectrodes to record from single neurons. Astrocytes have been 
shown to create a physical barrier between healthy and damaged tissue which creates an 
inhibitory environment for neurite extension (Raivich et al., 1997). This same physical 
barrier can electrically and physically separate the microelectrode from healthy cells 
(Turner et al., 1999) preventing neuronal recordings.  Therefore, similar to microglia and 
macrophages, some activation of glia is useful to support damaged cells, but, ultimately, 
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the goal is to control this activation and have the tissue return to its normal, resting state 
following the insertion of the microelectrode.   
Unfortunately, the exact time course of the cellular up-regulation following 
microelectrode insertion is not well understood and requires more study. The next section 
will examine how to monitor the time course of immunological events after 
microelectrode insertion using immunohistochemistry.  The approaches that have been 
used to minimize the immunological response will then be discussed with regards to their 
attempts to improve neuronal recordings. Finally, methods to monitor the effectiveness of 
neuronal recordings will be discussed.   
 
Measuring the Immunological Response 
 
Knowledge of the cellular response to microelectrode insertion does not 
immediately lead to a solution for successful implantation of the microelectrodes for 
chronically sustainable recordings.  While some of the factors that contribute to this scar 
(size of the device inserted, speed of insertion, etc) and mechanisms of scar formation, 
(recruitment of macrophages, activation of microglia, etc.) have been well studied 
(Klaver and Caplan, 2007), the relationship between single neuron recording and glial 
scar formation are less well understood.   
The effects of microelectrode insertion outlined above interact in such a way that 
despite the fact that the loss of recording occurs months after implantation, processes 
initiated during the acute phase of the response persist and contribute to the eventual 
encapsulation of the microelectrode. Traumatic brain injury research has shown that 
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mechanical trauma can initiate progressive degeneration that continues long after the 
traumatic event (Raghupathi et al., 2000). 
The ability to understand the brain’s response to microelectrode insertion on the 
cellular level is important for directing interventions to optimize the ability to obtain 
neuronal recordings indefinitely.  Because the cells involved in the reaction to the 
inserted microelectrode—in their activated states—express novel proteins on their 
surface, immunohistochemistry can be used to label cells that express these proteins and 
the amount of labeled tissue can be quantified.  Therefore, utilizing 
immunohistochemistry to classify and quantify the cellular response is an integral part of 
evaluating response reduction.  
 Proteins that are specific to the previously discussed cells of interested have long 
been identified and studied in the literature (Leung et al., 2008). During conventional 
immunohistochemical analysis, these proteins are associated with a primary antibody that 
will bind to the protein of interest (refer to Table 1). Once the primary antibody has 
bound to the protein, a second antibody tagged with a detection agent is then added to 
bind to the primary antibody.  This allows for visualization under a microscope for 
further analysis (Leung et al., 2008). 
 In order to prepare brain tissue for immunohistochemical analysis, the animal is 
usually perused transcardially—with a needle through the heart. The animal is first 
perfused with biological saline to flush the blood out of the tissue and then 
paraformaldehyde to fix the tissue. In some cases, analysis will be done on fresh tissue 
instead of fixed tissue (Kerns et al., 1992). Then, the entire animal is placed in the fridge 
for 1-2 days, following which time the brain is dissected. This period of time is not 
17 
 
 
always utilized for other immunohistochemical applications, but is important for studying 
microelectrode insertion as it gives the tissue time to fix and makes it less likely that 
tissue will be unintentionally removed by microelectrode cap removal. At this point, the 
tissue is often ”blocked” to remove unwanted sections of the brain from the area of 
interest.   Finally, the brain is placed in a surcrose solution for several days (Porada et al., 
2000). 
 After the brain has been equilibrated in the sucrose solution, the tissue is carefully 
frozen and sliced to a thickness between 10 microns and 30 microns.  Thinner tissue 
slices allow more of the tissue to be visualized but are harder to manipulate without 
damaging the tissue. The tissue can be sliced using a variety of tools, including the 
cryostat, microtome, and vibratome (Leung et al., 2008; Shain et al., 2003).  Once the 
tissue is sliced, it can be directly mounted to a slide for staining or it can be floated in 
phosphate buffered saline, stained, and then mounted onto a slide (Stensaas and Stensaas, 
1978).  Floating samples yield better staining because the stains can penetrate both sides 
of the tissue and, when transferred to a slide, bubbles underneath the tissue are less likely 
to form.  However, mounting cut tissue directly to slides makes the tissue more likely to 
rip and, more importantly for microelectrode-tissue response analysis, it is easier to 
monitor the relative depth of the tissue slice in the brain for later three dimensional data 
reconstructions.   
 In the past, the stain used to tag the protein of interest was a monochromatic stain, 
which only allowed one cell type to be viewed on a given tissue slice. However, newer 
stains utilize fluorescence, allowing antibodies that fluoresce under different wavelengths 
of light to be used simultaneously on the same tissue sample.  This allows for the labeling 
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of multiple cells on the same slice of tissue as well as a better image of the proximity of 
different cells types to one another since the images can be overlaid with imaging 
software to view all cell types simultaneously (Doroski, Brink, and Temenoff, 2007).  
 In order to better understand the brain’s response to microelectrode insertion, 
there are primary antibodies that stain the cells of interest as shown in Table 1.  
Examining tissue with and without microelectrode insertion with these types of stains can 
be useful in studying  the effect of microelectrode insertion on the presence and 
proliferation of the immunological cells of interest. 
 
Table 1: Primary Antibodies To Identify Cells of Interest 
This table lists the common primary antibodies that bind to the cells of interest to the 
microelectrode insertion reaction. This binding is due to the unique expression of proteins 
on the surface and within these cells.   
 
Cells of Interest  Primary Antibody 
Microglia ED1 (CD68) 
Macrophages ED1 (CD68) 
Astrocytes GFAP 
Neuron 
   Cell body 
   Cell Process   
 
NeuN 
MAP2 
 
 
 
 Most preliminary studies that use immunohistochemistry to better understand the 
effects of microelectrode insertion into the brain are qualitative (Cui et al.,2003; Turner et 
al., 1998).  However, there is an entire field of stereology that describes methods for 
counting or measuring the density of cell types and can aid in making quantitative 
measures of the effect and time course of cellular response to microelectrode insertion 
into the brain.  Unfortunately, limited studies have been done to date utilizing these 
quantitative techniques (Biran et al., 2005).  Moreover, the attempts to quantify the 
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morphological changes to up-regulated cells have not been well studied (Edell et al., 
1992). This information is critical to designing appropriate interventions that minimize 
the immunological reaction to microelectrode insertion in order to maintain healthy tissue 
around the microelectrode for sustainable, long-term recordings.   
 
Minimizing the Cellular Response to Microelectrode Insertion 
  
Several investigators have studied the effects of microelectrode insertion into the 
brain in the attempt to develop methods to minimize negative effects on the tissue from 
insertion (He, McConnell, and Bellamkonda, 2006). Further research should be done in 
this area because of the need to record for long periods of time from large numbers of 
single neurons simultaneously in vivo. The ability to complete these recordings is 
imperative to further our understanding of the functioning of the brain and to improve the 
success of potential clinical applications (He, McConnell, and Bellamkonda, 2006).  The 
methods utilized to attempt to minimize deterioration of the tissue around the inserted 
microelectrode include optimizing the geometry of the microelectrode, modifying the 
surface structure, and coating the surfaces with bioactive molecules to control the cellular 
response.  Each of these approaches will be examined next. 
 Investigators have explored the influence of microelectrode shapes, especially at 
the tip of the microelectrode on the brain’s reaction to microelectrode insertion. However, 
well controlled studies were not performed until the last half decade.  Szarowski et al. 
(2003) performed a comprehensive study on the long-term success of a variety of surface 
modifications and their affect on the chronic tissue reaction to the microelectrode. This 
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group studied size, surface texture, cross sectional shape, tip geometry, and insertion 
technique to determine the effects of these aspects on the short and long term reaction to 
microelectrode insertion. Microelectrodes with either a 2500 µm2, 10,000 µm2, or 16,900 
µm2 cross sectional area and either trapezoidal, square, or ellipsoidal cross sectional 
geometries were compared against one another. Smooth surface textures or micrometer 
rough surface textures, blade or rounded tip geometries, and slow and fast insertion 
techniques were also compared.  Using qualitative estimates of the amount of GFAP and 
ED-1 staining, they concluded that the size of the microelectrode had an effect on cellular 
up-regulation one week after insertion, but this effect was not evident after six weeks.  
However, more quantitative measures are necessary to fully explore these findings and 
their implications. 
Recent in vitro studies are beginning to suggest that changes in surface structure 
on the nano scale level can have an important effect on neurons and glia. McKenzie et al. 
(2004) studied the effect of carbon nanofiber coatings on astrocyte proliferation in-vitro.  
These coatings were either 60 or 200 nm and with either high or low surface energy. 
These results showed that microelectrode tips coated with fibers of smaller diameter and 
higher surface energy lead to a decrease in astrocytic adhesion. Since these cells are one 
of the primary cells believed to be involved in the encapsulation and isolation of the 
microelectrode in vivo, the group concluded that it may be possible to decrease the glial 
encapsulation of the microelectrode by manipulating the surface structure of the 
microelectrodes at the nano-scale (McKenzie et al., 2004). 
 The effects of modifying the surface of the microelectrode with surface polymers 
have also been studied (Buchko et al., 2001; Xiao et al., 2006). Electrochemical 
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polymerization was used to deposit both polymer and bioactive molecules onto the 
surface of microelectrodes to improve the signal conduction at the recording site surface 
and to attract neurons (Cui et al., 2001; Kim et al., 2003; Xiao et al., 2006).  These 
devices were tested both in vitro and acutely in vivo. These experiments were able to 
show high levels of function as well as preferential neuronal growth on the surface.  
Chronic testing showed that this approach could produce stable neural recordings at some 
sites after one week, following which time the recordings were lost (Cui et al., 2003).  
Surface coatings such as silk-like polymer having fibronectin fragments (SLPF) and 
nonapeptide (CDPGYIGSR) have also been found to increase neuronal growth and 
decrease glial proliferation (Cui et al., 2001). Other surface coating such as fibronectin 
and laminin have also been used on the surface of microelectrodes as they are 
extracellular matrix proteins that help guide cell movement and facilitate cell adhesion 
(Hynd et al., 2007; Stauffer and Cui, 2006). Therefore, conducting polymers may provide 
improved interfaces between microelectrodes and neural tissue but more work is required 
to better understand this interface and how conducting polymers can improve neuronal 
recordings chronically.  
The effect of surface structure was also studied comparing mesostructured porous 
silicon (PS) to nanostructured porous silicon (PS) as novel surface coatings for ceramic-
based microelectrodes (Moxon et al., 2004).  In vitro studies showed that neurons 
preferred the nanostructured surface by extending significantly more neurites while glial 
cells avoided the nanostructured surfaces, suggesting that this surface may be useful for 
targeting appropriate cell types in vivo.  Subsequent in vivo studies showed that 
microelectrodes coated with nanostructured porous silicon could be used to record single 
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neurons.  More studies over longer time periods are necessary to determine if these 
surfaces have a useful effect for improving long-term biocompatibility.   
 There are generally three approaches to using bioactive molecules to improve 
microelectrode recording: delivering drugs via microfluidcs, systemic injection of drugs 
to minimize the immunological response, and attaching biomolecules to the surface 
through some type of chemical bond (conjugation). Some investigators have attempted to 
incorporate microfluidics to deliver novel drugs to the insertion site in order to attenuate 
the biological response to microelectrode insertion (Retterer et al., 2008).  Researchers 
studying microfluidics have incorporated drug delivery channels into the microelectrode 
tips. In order to make these fluid channels beneficial though, fabrication technique must 
be utilized that can incorporate these channels without greatly increasing the size of the 
microelectrode tip. The groups who have been successful in fabricating microelectrodes 
with incorporated microfludics channels (Retterer et al., 2004; Cheung et al.,2003) found 
that it was possible to deliver labeled compounds of similar molecular weight to active 
drugs into tissue like materials in-vitro as well as in-vivo over short time periods. 
However, since no long term studies of these microfludics have been completed, there is 
no way to know if the same cellular processes that physically isolate the microelectrode 
from the normal cellular environment will occlude these channels and render them 
useless.   
 Koyoma et al. investigated the effects of BQ788 on reactive astrocytes. BQ788 is 
an endothelin ETB receptor antagonist. Endothelin molecules have been shown to regulate 
the function of astrocytes through DNA synthesis. Reactive astrocytes and activated 
microglia are the main cells that express the ETB receptor. Injury was induced in male 
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rats by a unilateral stab wound using a razor blade. BQ788 was administered by 
continuous infusion and showed a significant decrease in the GFAP staining at two weeks 
post injury. However, this ETB receptor antagonist showed an increase in the number of 
microglia.  Therefore, endothelin has shown potential to be used in future experiments, 
though one must investigate the effects of this receptor antagonist for a longer time 
period. The effects of this receptor antagonist also need to be investigated in vivo.  
Tomobe et al. (1996) investigated the effect of anti-coagulation factor protein S 
on activated astrocytes. Protien S is a plasma protein expressed in cultured glial cells. 
Injury was induced by scratching cultured rat astrocytes in vitro.  Protein S activity was 
measured by using a functional clotting assay in the presence of serum and in the absence 
of serum. At a concentration of 100 nM, Protein S suppressed the proliferation of reactive 
astrocytes by 50%. At a concentration of 300nM, it suppressed the proliferation by 90%.  
The mRNA expression of Protein S was also investigated and a marked increase in the 
concentration was observed 15 hours after injury.  This up-regulation of Protein S mRNA 
expression after injury suggests that Protein S may be involved in regulation astrocyte 
proliferation after injury. 
In another set of experiment, tumor necrosis factor-β1 (TNF-β1) was 
administered to the cultured astrocytes since TNF-β1 is known to be a strong inhibitor of 
astrocyte proliferation. Cell growth was assessed by incorporating [3H] thymidine and 
bromodeoxyuridine BrdU in cultured astrocytes for 24 hours.  Reactive astrocytes were 
reduced to 50% of control level when TGF-β1 was administered at a concentration of 20 
ng/ml. Protein S had a comparable effect on the astrocytes at a concentration of 100 nM.  
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These interventions clearly show an inhibitory effect on astrocyte proliferation and they 
should be investigated in vivo to fully understand their potential. 
Steroids also have the potential to improve neuronal recordings in vivo because of 
their ability to reduce inflammation.  The effects of dexamethasone, an anti- 
inflammatory synthetic glucocorticoid was investigated on astrocytes (Spataro et al., 
2004; Zhong and Bellamkonda, 2007).  A single dose of dexamethasone was 
administered to animals after surgical implant of microelectrodes into the brain. The 
animals were sacrificed at week 1 and week 6 and the brain sections were stained for 
GFAP, CD11b and laminin.  Reactive astrocytes were observed around the device shank. 
Interior to the layer of reactive astrocytes, activated microglia was observed. The reactive 
astrocytes transformed into a compact sheath by week 6. The astrocyte layer extended to 
diameter of 400 micrometer from the device shank. Laminin staining and CD11b staining 
was observed to be minimum. Since a single dose of dexamethasone did reduce the glial 
response to an extent, dexamethasone was injected daily for one week.  At six weeks, a 
compact sheath of astrocytes was observed but was poorly developed and showed no 
significant hypertrophied morphology. However, there was increased laminin and CD11+ 
staining. These studies suggest that dexamethasone has the potential to regulate astrocyte 
proliferation but additional side effects of this treatment should be studied. 
Dexamethasone, along with other neurotrophic factors, can be used in drug delivering 
systems at the site of microelectrode implantation to curtail the problem of glial scarring 
(Kim and Martin, 2006). 
Other groups have proposed to immobilize biomolecules on their microelectrodes 
to mediate the cellular response. Azemi et al., (2008) immobilized L1 molecules—which 
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are neuronal adhesions molecules indicated in the neuronal pathways of mobility and 
growth—on laminin constructs placed around the microelectrode. The group was 
successful in promoting the pathways involved with the L1 molecule surrounding the 
inserted microelectrode and therefore showed better biocompatibility of this surface 
compared to control groups (Azemi et al., 2008). Other compounds, such as BDNF (Jun 
et al., 2008) and polymer poly(3,4-ethylenedioxythiophene – PEDOT) (Richardson-
Burns et al., 2007), have also been immobilized on microelectrode constructs and shown, 
in vitro, to improve neuronal proliferation around the microelectrode material.  
Another compound studied for the use of mitigating neuronal injury is 
Poloxamer-188. Poloxamer-188 is a water-soluable, non-ionic surfactant first studied for 
use in mitigating traumatic brain injury. Due to its surfactant properties, it is believed to 
work by sealing damaged membranes, thus preventing contamination of the extracellular 
space by intracellular proteins and promoting cell survival (Serbest, Horwitz, and Barbee, 
2005; Serbest et al., 2006). However, there is no work in literature of applying this 
compound to implanted microelectrodes.  
 
Evaluating the Success of Response Reduction  
  
The most important practical indicator of successful reduction of the cellular 
response to microelectrode insertion is the ability to continue to obtain consistent 
recordings of single neuron action potentials over a chronic period of time.  
The scar tissue that begins to surround the microelectrode following insertion 
electrically isolates the microelectrode from the brain environment. Therefore, as greater 
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amounts of scar tissue begin to build up, it is harder to discern single actions potentials 
from the background noise (Winter, Cogan, and Rizzo, 2007). These single action 
potentials are the signal of interest and therefore, as the ability to record these single 
action potentials decreases, so do the ability to use the information for different 
applications.  
 Some groups have achieved chronic recordings from current implantation 
techniques. Porada et al. (2000) were able to record discernable action potentials from the 
brain of a monkey for more than a year. Importantly, they quantified their recording 
stability through four measures: “spike shape, spike train autocorrelograms, spike 
frequency, and range of peak amplitudes.”   
Spike shape was evaluated by a vector made from three spike characteristics. The 
first characteristic was the amplitude of the first phase of the spike, the second 
characteristic was the amplitude ratio comparing the first and second phases of the spike, 
and the third characteristic was ‘inter-peak-interval’ of the spike. These three components 
yielded a numerical vector that could be normalized and used to compare the spike shape 
between different recording sessions.  These types of quantitative measures are useful for 
comparing results across groups. (Porada et al., 2000).   
 Another group of investigators attempted to quantify the effect of various cellular 
foreign body response components through the classification of impedance normalized to 
saline (Merrill and Tresco, 2005).  The concept underlying this measurement is that as the 
glial scar builds up, the buildup increases the impedance between the recording site and 
the tissue.  Therefore, impedance should be inversely correlated with the quality of the 
recording, although this has never been shown.  In fact, most studies of neural recordings 
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that measured impedance found no correlation between the quality of the recording and 
the microelectrode impedance.  However, in vitro, Merrill and Tresco (2005) 
demonstrated that cellular adhesion to the recording site surface yielded changes in the 
impedance varying from 20% to 80% and this change was shown to persist for a period 
of weeks. However, this change in impedance was not shown, in vitro, to negatively 
affect the ability to record (Merrill and Tresco, 2005).  Therefore, it is not clear that this 
change in impedance will address the quality of the recording. 
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4. OVERVIEW OF EXPERIMENTATION 
 Adult, male, Long-Evans rats were anaesthetized with Nembutal and implanted 
with microelectrodes into the somatosensory cortex (see Microelectrodes, below). 
Following deep anaesthization, the animals were implanted bilaterally with 
microelectrodes into the somatosensory cortex (see Implantation of Microelectrodes, 
below). The exposed brain tissue was protected with a coating of agar gel and the 
microelectrodes were secured to the skull with dental cement. The incision was then 
closed with surgical staples and the rat was allowed to recover (see Implantation of 
Microelectrodes, below).  
 At one, two, four, or six weeks following implantation, the rats were euthanized 
with an overdose of Nembutal and perfused transcardially with phosphate buffered saline 
(PBS) followed by 4% paraformaldehyde. Carcasses were then placed in the refrigerator 
for two days and dissected on the third day to remove the brain and block the tissue. 
Tissue samples were then placed in 30% sucrose solution for a three day equilibration 
period and subsequently sectioned on a vibratome into 30 micron sections (see Perfusion 
and Tissue Processing, below). Sections were immediately mounted onto slides, which 
were ringed with rubber cement and treated with antibodies for staining (see Histology, 
below). 
 Once the tissue samples were treated with staining antibodies, two quantification 
methods were applied. Samples stained for macrophages and neuron cell bodies utilized a 
cell counting technique to quantify cellular response to microelectrode insertion (see 
Counting Method, below) and samples stained for astrocytes were analyzed with an 
intensity of stain quantification to study cellular response (see Intensity Method, below).  
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5. MATERIALS AND METHODS 
 
Microelectrode Fabrication 
 
 Prior work from this lab has created a method for inducing porosity on the 
microelectrode surface. The porous silicon coating of our microelectrodes is fabricated 
via photoelectric etching. This method is beneficial because it offers several process 
variables that allow for control of pore formation and morphology.  
 In order to control pore formation and morphology, a variety of factors are varied 
including: 1) anodic current density, 2) HF concentration, 3) choice and concentration of 
substrate dopant, 4) illumination wavelength, and 5) direction of incidence. 
 In preliminary studies, ten primary samples were studied in vitro to determine 
optimal electrical, mechanical, and biological variations. Samples included n- and p-types 
Silicon wafers and dopants were either Arsenic, Phosophorous, and Boron. Preliminary 
data showed that only three samples were of sufficient porosity (>70%) and further in 
vitro analysis was done on these three samples.  
 Following cell culture analysis on microelectrode surfaces, type seven was the 
most successful and is therefore the type of microelectrode surface utilized for this 
experiment. Type seven surfaces are characterized as having significant porosity with 
deep pores. The deep porosity can be seen in the three dimensional image shown in 
Figure 5. Figure 6 is a visual representation of the entire electrode shaft completed 
through this process.  
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Figure 5: Three Dimensional Representation of Surface Porosity 
Previous work done in this lab obtained this three dimensional image showing the depth 
of pores in the porous silicon samples implanted for this thesis.  3-D glasses are required 
to see this image clearly. 
 
 
 
Figure 6: SEM Image of Microelectrode Shaft 
Previous work done in this lab obtained this composite 50x magnification images of a 
diced silicon-based microelectrode with porous silicon coating. Note: the scale bars 
indicate 1000µm or 1.0mm. Although the same process was used to make this electrode 
shaft, larger wafers were implanted for this thesis.  
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Implantation of Microelectrodes 
 
 All in vivo surgical procedures were performed utilizing sterile techniques 
approved by the Drexel University Institutional Animal Care and Use Committee 
(IACUC).  To prepare the adult, male, Long-Evans rats for surgery, rats were 
anaesthetized with a weight adjusted amount of intraparitenial Nembutal. The rat’s heads 
were shaved and the area was disinfected with an alcohol swab followed by a butadiene 
swab.  
 After full anaesthetization was observed, rats were placed on the stereotax, an 
incision was made to expose the skull, and the skull was centered on the stereotax to 
bregma. Holes were drilled into the skull at (0, +-3.5), (-3,+-2), and (-5.5, +-4.5) in the 
anterior/posterior and lateral directions and the microelectrodes were inserted via a tool 
mounted on the sterotax. The microelectrode was cleaned prior to insertion with a 
sonicating solution of water followed by a sonicating solution of sterile alcohol. 
Following this sterilization procedure, the microelectrode was dried with compressed air 
and subsequently inserted.  
Holes in the skull were then filled with agar gel to protect the exposed brain tissue 
and the microelectrodes were secured to the skull with dental cement. The incision was 
then closed with surgical staples and the rat was allowed to recover from anesthesia in a 
heated environment. Rats were each monitored frequently until they fully recovered from 
anesthesia, and then once per day for the remainder of the study. Seven rats were 
implanted with six independent mock microelectrode tips each (some related to other 
studies) for experimentation for this thesis.  
32 
 
 
 
Perfusion and Tissue Processing 
 
 At one week, two weeks, four weeks, or six weeks following implantation, the 
rats were euthanized with an overdose of Nembutal or Euthasol and then perfused 
transcardially with 0.5 L of ice cold PBS followed by 0.5 L of ice cold 4% 
paraformadelhyde. After perfusion was complete, the carcasses were placed in the 
refrigerator for two days to allow the tissue to fully absorb the fixants. Additionally, this 
period of time allows the tissue to solidify to minimize tissue tearing during the removal 
of the microelectrode. Following this time period, the brains were dissected and blocked 
to separate microelectrode holes and placed in 30% sucrose solution to equilibrate for 
three to five days. 
 Following the equilibration period, the tissue was sliced using a vibratome into 30 
µm sections. These sections were collected serially in four groups and mounted onto 
slides.  
 
Histology 
 
 After sections were mounted onto the slides, the slides were then ringed with 
rubber cement to create wells and treated with antibodies to stain for macrophages, 
neuron cell bodies, neuron filaments, astrocytes. Group one received ED1 and GFAP to 
stain for macrophages and astrocytes, group two received NeuN and GFAP to stain for 
neuron cell bodies and astroyctes, and group three received MAP2 to stain for neuron 
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filaments. The final group received a nissel stain, to mark all cells and provide as a 
comparative control.  
 To prepare tissue for staining, the sections were washed in PBS and then blocked 
with goat serum. The primary antibody was then applied overnight at a 1:1000 dilution.  
 Following the primary antibody incubation period, the tissue was washed in PBS 
and incubated in the secondary antibody for two hours at a 1:100 dilution. The tissue was 
then washed again and coversliped with Vectashield to help preserve tissue and stain 
quality.  
 
Counting Method 
 
 Once the tissue had been stained, macrophages and neuron cell bodies were 
quantified utilizing a counting method. Utilizing a fluorescence microscope, four images 
were captured of each section. The center of the microelectrode hole was used to visually 
create an axis so that each of the four images captures a unique quarter of the 
microelectrode hole and the surrounding tissue.  
 After the images were captured, our unique MATLAB rountine was used to 
define the radial area 50 µm from the edge of the hole and 150 µm from the edge of the 
hole. The program was then used to randomly select 15% of the tissue in each of these 
two areas and cells were manually counted in these representative areas. As the sampling 
is random, if a larger proportion of the tissue needs to be sampled, the procedure can be 
repeated to sample more of the tissue. These data were then used to compare cellular 
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proliferation with distance from the microelectrode site in a paired t-test or ANOVA 
format. 
 
Intensity Method 
 
    After the tissue was stained, astrocyte response to microelectrode insertion was 
quantified utilizing an intensity method. Utilizing a fluorescence microscope, four images 
were captured of each section. The center of the microelectrode hole was used to visually 
create an axis so that each of the four images captures a unique quarter of the 
microelectrode hole and the surrounding tissue. Equal exposure times were utilized for all 
images captured to equalize the amounts of background staining captured.   
 After the images were captured, background staining was removed by calculating 
the intensity of staining in control tissue and subtracting this level of intensity from all 
images captured. Then, our unique MATLAB protocol was used to draw four horizontal 
lines. The edge of the microelectrode tract (empty space) was manually defined by the 
program operator from visual inspection of the intensity profile. After the lines were 
drawn, MATLAB determined the intensity of staining at each pixel on the line. These 
data were then used to compare the amount of astrocyte up-regulation compared with 
distance from the injury site. This method is discussed in depth in the design component 
section.   
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6. DESIGN COMPONENT 
 
Statement of Statistical Challenge 
 
 Understanding astrocytic up-regulation is important for quantifying tissue 
response to implanted microelectrodes as well as to attempting to improve 
biocompatibility of the implanted microelectrodes, but quantifying this response is 
difficult. Although cell counting and the related statistical methodologies are frequently 
utilized following immunohistochemical treatment of tissue, this is not an appropriate 
approach for quantifying astrocytic cell response. Primarily, counting these cells is 
difficult because the GFAP stain labels the processes of the astrocyte as well as the cell 
body and therefore discriminating one cell from another is difficult. Also, even if it was 
possible to easily count cells in this methodology, cell counts would not include 
information regarding the hypertrophied nature of upregulated cells. Therefore, a method 
is required which incorporates quantification of both cells present as well as their 
hypertrophied character.    
 
Statistical Analysis Protocol 
 
Our approach to GFAP quantification was adapted from the work done by Biran 
et al. (2005). This approach utilizes a line intensity analysis over multiple horizontal lines 
of an image of the tissue surrounding the inserted microelectrode. Due to the fact that our 
lab did not have access to the advanced statistical and image software utilized by Biran et 
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al., we designed a unique MATLAB routine to generate the line intensity profiles from 
our images. See Figure 7, below, for a visual representation of the lines drawn by the 
routine.  
 
Figure 7: Visual Representation of Line Intensity Analysis 
Example of an microelectrode hole quadrant analyzed in a unique MATLAB routine to 
determine GFAP expression (magnification 10x). Astrocytes can be specifically stained 
against GFAP and this staining is proportional to cell proliferation and level of 
hypertrophy. However, it is difficult to quantify this staining through traditional cell 
counting methodology. Therefore, we utilized a line intensity spectrum of magnitude of 
staining along a horizontal line across the image. Five randomly placed lines are drawn 
(shown in red) and the intensity displayed. These intensities are then zeroed with the edge 
of the hole chosen as the distance 0 (shown in yellow). The data compiled from these five 
lines can then be averaged and statically analyzed to determine differences between the 
porous images and the nonporous images. 
 
 
 In order to capture information of both cell proliferation and level of cell 
hypertrophy, the MATLAB routine processes a series of steps for each image. First, the 
image must be opened in the routine by a user. Next, it must be specified whether the 
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image was taken of the right or left side of the microelectrode hole because this will flip 
the alignment of the tissue and the blank space on the image.  
Once the image is opened and the side is specified, the program places five 
horizontal lines randomly across the image (artificially shown in red in Figure 7) and the 
intensity of staining is quantified on an arbitrarily determined intensity scale that is 
consistent for all images analyzed in the system. This intensity profile generates an 
intensity value for each pixel along the line. Then, the user views a graphical 
representation of the line intensity to determine the edge of the hole and zero the data at 
this edge (artificially shown in yellow in Figure 7). See Figure 8 for an example of the 
intensity profile used. 
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Figure 8: Graphical Representation of Intensity Profile 
In this graphical representation of the intensity profile, the user must pick the edge of the 
hole, which is characterized by a very low intensity followed by large peak as the image 
transitions from the empty space of the microelectrode track to the bright staining of the 
compact astrocytic sheath surrounding the hole.  
 
 
It is important to zero the data points to the edge of the hole for two reasons. The 
first is that the information desired is the cellular character at given distances from the 
edge of the microelectrode. The edge of the image is an arbitrary set point where as 
zeroing all data with the edge of the hole allows all line intensities to be combined and 
analyzed with regard to their distance from the microelectrode. The second reason for 
zeroing the data points in this way is that any intensity artifacts or loose tissue in the 
space of the hole is irrelevant to the data analysis and should be removed.   
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 Once the data is obtained and zeroed, the data from these five lines can then be 
averaged and statistically analyzed to determine the effect of microelectrode treatment. 
Figure 9 shows both the histological image and graphical representation of the binned 
average intensity profile for a typical image. To determine if the difference in GFAP up-
regulation around these surfaces was statistically significant, a paired t-test or an 
ANOVA was implemented. To assess the effect of porous silicon as a function of 
distance from the edge of the hole, a two-way ANOVA was performed.  This analysis 
was done at one week.  For the the two, four, and six week data, we were only interested 
in the difference between PS and smooth and we therefore performed a paired t-test. A 
paired, two tailed t-test was appropriate because each microelectrode contained both 
types of surface and the tissue was maintained in the original pairing for data analysis. It 
should be noted that this type of within subject control is important due to the inherently 
variable nature of in vivo data and the relatively modest sample size that can be obtained 
due to housing and cost constraints of maintain the animals.  
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Figure 9: Example Output of Intensity Profile Protocol 
The image on the left represents the histological image obtained of one quarter of a 
typical microelectrode track. The graph on the right shows GFAP specific staining 
intensity of this histological image.  
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7. RESULTS 
 
Two animals were implanted with Spire Sample Type 7 mock microelectrode tips 
(100 µm diameter, 7 mm long). The samples were implanted into the cortex of the rats, 
which were sacrificed after one week. The brains were removed and stained for glia 
(GFAP), microglia/macrophages (ED-1), and healthy neurons (NeuN). An example of 
this staining can be seen in Figure 10.  
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Figure 10: Immunohistochemical Staining Adjacent to Implanted Device at  
One Week Post-Insertion 
Immunohistochemical staining adjacent to PS devices (‘mock’ microelectrodes), where 
one side (left on each panel) is smooth and the other (right) is nanostructured porous 
silicon (nPS). (A) GFAP expression, which marks astrocytes, showing less staining on 
the nPS side than the smooth side. (B) ED1, which stains for macrophages and microglia 
expression, is significantly reduced on the porous side of the microelectrode compared to 
the smooth side. (C) NeuN staining, which marks neurons, shows significantly more 
staining on the nPS side than the smooth side. This particular animal was killed one week 
after the PS device was implanted. The black line was added to show how the smooth 
side was discriminated from the porous silicon.  
 
 
The staining intensity for GFAP for the tissue adjacent to the smooth surface was 
consistently higher than the staining adjacent to the porous silicon surface, but the 
difference did not reach statistical significance (P = 0.054, F = 3.75, n = 217) (Figure 
11A). As expected, as the distance from the device increased, the intensity of the GFAP 
staining decreased and this difference was significant (P < 0.001, F = 6.4, n = 217). This 
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result is similar to other studies that showed an increase in glial activation near the 
microelectrode.  
 
 
Figure 11: Graphical Representation of Tissue Reaction to Microelectrode Insertion at 
One Week Post-Insertion 
Decreased glial activation and increased neurons adjacent to the porous silicon surface 
compared to smooth surfaces. (A) Astrocyte activation around each microelectrode hole 
was quantified by measuring the fluorescence intensity within 50 µm increments from the 
edge of the hole left by the microelectrode (refer to the methods and design component 
sections for details). While the florescence intensity adjacent to the porous silicon surface 
was consistently less than that around the smooth surface, the differences were not 
significantly different at any distance. (B) Microglia and macrophage activation around 
each microelectrode hole was significantly greater adjacent to the porous silicon surface 
than the smooth surface. (C) Neurons were more likely adjacent to the porous silicon 
surface than the smooth surface within 150 µm from the edge of the PS device. However, 
by 200 µm, there were fewer neurons adjacent to the porous silicon surface compared to 
the smooth surface.   
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In addition to quantifying the GFAP intensity around the devices, we also 
quantified the number of ED-1 positive cells around the device. Similar to the GFAP 
staining, the amount of ED-1 staining adjacent to the smooth surface was greater than the 
staining around the porous surface but this difference was significant (P = 0.01, F = 6.66, 
n = 89) (Figure 11B). In a manner similar to the GFAP staining, as the distance from the 
device is increased, the number of ED-1 positive cells also significantly decreased for the 
tissue around both the smooth and porous surfaces (P < 0.001, F = 12.77, n = 89). The 
significant difference in ED-1 staining around the porous surface compared to the ED-1 
staining around the smooth surface suggest that modifying the surface of the 
microelectrode is sufficient to alter the up-regulation of microglia and recruitment of 
macrophages around a microelectrode.  
Finally, we quantified the NeuN staining around the device and counted the 
number of positively-stained cells. Similarly for GFAP and ED-1 staining, there was a 
significant effect for distance from the PS device (P < 0.001, F = 29.81, n = 237) but the 
number of neurons increased as the distance from the PS device increased, the opposite 
from the decreases in GFAP or ED-1-positive staining, as one might expect (Figure 11C). 
There was also a significant interaction between distances from the PS device and the 
porous vs. smooth side of the device (P < 0.001, F = 6.84, n = 237). Post-hoc test 
revealed significantly more NeuN positive cells adjacent to the porous surface than 
adjacent to the smooth surface (P < 0.001) within 50 µm of the PS device. This difference 
decreased at 100 µm (P = 0.050) and was gone by 150 µm. At 200 µm, there were 
significantly fewer neurons adjacent to the porous silicon surface compared to the smooth 
surface. Therefore, modifying the surfaces of the microelectrodes not only reduces the 
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up-regulation of microglia and recruitment of macrophages but also increases the number 
of healthy neurons within recording distance around the recorded neurons (within 100 
µm).  
Taken together, these data suggest that the porous surfaces influence the glial scar 
formation and support the health of neurons at one week post insertion. Thus, the 
bioactive properties of nanostructured porous silicon identified by previous experiments 
by this lab in vitro can be maintained in vivo at one week post insertion.  
To further analyze the effects of the porous surface found in vivo at one week 
post insertion, animals were implanted with Spire sample type 7 mock microelectrode 
tips (100 µm diameter, 7 mm long) and were sacrificed at 2, 4, or 6 weeks post insertion.  
The GFAP staining was analyzed to further study the consistent, but at one week not 
statistically significant, decrease in GFAP specific staining surrounding the 
microelectrode shaft. In this way, it was possible to determine if the lack of statistical 
significance in this decrease, at one week post insertion, was due to truly statistically 
insignificant circumstances or to data that was not robust enough.  
 
 
Table 2: Summary of Experimental Units and Conditions 
This table depicts a summary of experimental units at each of the time points. During 
tissue processing, some tissue samples were damaged and could not be analyzed.  
 
Weeks Number of Experimental 
Units (Animals) 
Number of Tissue 
Slices Analyzed 
Intensity Line 
Profiles Obtained 
2 2 12 90 
4 2 16 140 
6 1 12 90 
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 At two weeks post insertion, there was the most inconsistency in GFAP staining 
intensity. At 0-50 µm, 100-150 µm, and 150-200 µm, the GFAP staining intensity 
adjacent to the porous surface was greater on average but not significantly different from 
the smooth surface (Figure 12). However, at 150-200 µm, the intensity of the GFAP 
staining was significantly greater around the PS surface than the smooth surface (p<0.05). 
These findings are inconsistent with results at one week, four weeks, and six weeks and 
at this time, there is no evidence to explain these findings. More experimentation is 
required to determine if the cellular mechanisms acting in the two week post insertion 
timeframe are unique or if these results are anomalous.  
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Figure 12: Graphical Representation of Tissue Reaction to Microelectrode Insertion at 
Two Weeks Post-Insertion 
Graphical representation of GFAP staining intensity as distance from the microelectrode 
track increases at two weeks post insertion. The asterisk represents a significance 
difference in GFAP staining intensity (p<0.05).  
 
 
 At four weeks post insertion, there was roughly equivalent GFAP intensity at 0-50 
µm and 50-100 µm adjacent to the porous surface and the smooth surface (Figure 13). 
However, as the distance from the microelectrode track increases to 100-150 µm, the 
average GFAP intensity is less adjacent to the porous surface as compared to the smooth 
surface and this difference approaches significance but is not significant by our cut off 
value (p=0.086). As the distance from the microelectrode track then increases to 150-200 
µm, the average GFAP intensity is significantly less adjacent to the porous surface as 
compared to the smooth surface and this difference is significant (p<0.05). This would 
suggest that, at four weeks post insertion, the decrease in average GFAP intensity 
adjacent to the porous surface at one week post insertion is beginning to disappear but 
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that the decrease in average GFAP intensity at further distances (100-200 µm) becomes 
significant from the cellular processes occurring between one and four weeks. This may 
be due to the fact that the total recruitment of astrocytic cells is less in proximity to the 
porous surface but other factors are still contributing to the effects in very close proximity 
to the electrode.  
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Figure 13: Graphical Representation of Tissue Reaction to Microelectrode Insertion at 
Four Weeks Post-Insertion 
Graphical representation of GFAP staining intensity as distance from the microelectrode 
track increases at four weeks post insertion. The asterisk represents a significance 
difference in GFAP staining intensity (p<0.05). The cross represents a p value 
approaching statistical significance (p=0.086).  
 
 
 At six weeks post insertion, there is a decrease in GFAP staining intensity 
adjacent to the porous surface as compared to the smooth surface in all distance 
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increments from the microelectrode track (Figure 14). This difference is significant from 
0-50 µm (p<0.05) and approaches significance at 50-100 µm (p = 0.078). However, this 
difference is not significant from 100-200 µm. Taken in context with the results from 
four weeks post insertion, these data suggest that all traumatic damage inflicted during 
microelectrode insertion has been mitigated and the chronic response to the 
microelectrode has begun. In this way, lower average intensity adjacent to the porous 
surface may be directly due to more favorable cellular response to the nanostructured 
surface. Moreover, the fact that this difference is only significant in close proximity to the 
microelectrode should be expected, as the further the distance is from the microelectrode 
track, the less interaction the cells have with the surface itself.  
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Figure 14: Graphical Representation of Tissue Reaction to Microelectrode Insertion at 
Six Weeks Post-Insertion 
Graphical representation of GFAP staining intensity as distance from the microelectrode 
track increases at six weeks post insertion. The asterisk represents a significance 
difference in GFAP staining intensity (p<0.05). The cross represents a p value 
approaching statistical significance (p=0.078).  
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8. DISCUSSION 
The prior work done by this lab, in vitro, to validate improved biocompatibility of 
porous microelectrode surfaces was validated in vivo by work completed for this thesis. 
Tissue around the microelectrode at one week post insertion had a lower density of glia 
and activated microglia/macrophages and more neurons. At six weeks post insertion, the 
tissue around the microelectrode has a lower density of glia closest to the microelectrode. 
These data—together with the in vitro data obtained in prior experiments—suggest that 
nanostructured materials will make a good surface for microelectrodes and should be 
tested for chronic periods on real microelectrodes so that their effect on actual neural 
recordings can be made. Correlations between histological analysis of cellular up-
regulation and loss of discriminable single unit action potentials will provide an 
important bridge to understanding how cellular up-regulation affects neuronal recordings. 
Additionally, while there is less glial activation in the tissue adjacent to the porous silicon 
side at one, four, and six weeks, further work must be done using fabricated 
microelectrodes to test the ability to increase the number and duration of viable recording 
sites.  
 Utilizing our unique design for quantitatively assessing cell regulation around the 
microelectrode, we have shown successful quantification of astrocyte up-regulation in the 
brain tissue surrounding the site of microelectrode insertion. This is an important aspect 
of understanding the effects of cell morphology, not just cell count, imparted by the 
astrocytes surrounding the microelectrode. Therefore, future work done to improve the 
biocompatibility of inserted recording microelectrodes can be adequately assessed. This 
process of assessing the cellular response will aid in the creation of a more biocompatible 
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microelectrode and could help bring the therapeutic benefits of implanted recording 
microelectrodes to human patients.   
 Obtaining extracellular electrical potential recordings from microelectrodes 
implanted in mammalian cortex requires the electrical fluctuation due to changes in 
membrane potential of neurons to occur near the recording microelectrode. This allows 
for a recording of the sum of the electrical activity around the recording site to be 
obtained. Therefore, if the microelectrode is close enough to a cell of interest, usually 
within 100 µm, the potential change due to an action potential can be recorded. However, 
if the microelectrode is too far away, the amplitude of the action potential degrades and is 
corrupted by other potential changes from other cells and can no longer be discriminated 
from the background activity. Therefore, the recording site of the microelectrode must 
remain very close to the neurons. Since the statistical significance of a decrease in 
astrocytic up-regulation increases in the range of 0-100 µm as the time post-insertion 
approaches the chronic state (six weeks), this would suggest that the porous surface 
induces more favorable reaction for chronic insertion. Unfortunately, although the 
decrease is statistically significant, more work will be needed to determine if this 
difference is biologically significant. The difference in up-regulation imparted by the 
porous surface is likely not to be great enough in magnitude to maintain a fully 
uninterrupted microelectrode-tissue interface.  Additionally, insertion of the 
microelectrode devices not only induces gliosis, but this process reduces the density of 
neurons around the microelectrode and this will likely require multiple approaches to 
alleviate.  
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 The significant decrease in all types of glial staining as the distance from the PS 
device increases at one week post insertion suggests that there is a significant up-
regulation of these cell types in response to the microelectrode insertion. While one might 
initially expect that no increase in glial activation is the most desirable state after 
microelectrode insertion but this is unlikely to be this case. The initial insertion of the 
microelectrode will damage neurons, tear dendritic and axonal processes, and perhaps 
cause some cell death. Damage to the blood brain barrier (BBB) is also likely. The fact 
that the up-regulation of glial cell types was less adjacent to the porous silicon surfaces 
compared to the smooth surface suggests the porous surface is more supportive of 
damaged neurons, and less likely to further induce glial up-regulation due to foreign body 
responses. This was supported by data at longer time points, with special emphasis on six 
weeks post insertion, where decrease in glial up-regulation was significant close to the 
microelectrode track. However, more experimentation is needed to determine if the data 
obtained at two weeks post insertion was anomalous with regards to glial up-regulation or 
if other factors during this time period affect the response.    
 Negative correction between glial cell types and neurons at one week post 
insertion suggests that perhaps the increase in glia pushes the neurons away from the 
microelectrode. The fact that, at 200 µm, there were significantly more neurons on the 
side adjacent to the smooth microelectrode supports this idea that neurons are pushed 
away rather than dying. If neurons are pushed away, the fewer that exist near the 
recording site, the more there must be at some distance further from the recording site 
surface. Although more work is needed to confirm this, it is likely that the nanostructured 
porous surfaces are less likely to push the neurons away than a smooth surface.  
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It is important to note that it is unlikely that modifying the surface alone will be 
sufficient to maintain single neuron recordings for neurorobotic applications in humans. 
There are two major effects of chronically implanting arrays of microelectrodes into the 
brain. The first is due to the action of inserting the microelectrode through the tissue that 
will damage and tear neuronal and glial processes, exposing the extracellular 
environment to intracellular proteins and damaging the BBB. The exposure of the 
extracellular environment to both intracellular and blood proteins initiates a cascade of 
events that can help to remove the damaged tissue and debris and heal the tissue or, if the 
damage is severe, create a glial scar that walls of the microelectrode from recording 
single neurons.  
The second major effect is the continued existence of the microelectrode in the 
neural tissue, commonly referred to as the foreign body response. If the brain is subject to 
a stab wound with a device about the size of a microelectrode (meaning that the device is 
inserted into the tissue, withdrawn and the dura and skull replaced), the wound will heal 
within six months. Therefore, it will be difficult to identify the location of the wound if 
the stab was done under controlled, sterile conditions. However, if the device used to 
create the stab wound is left in place, a glial scar will form around the device, effectively 
walling it off from the healthy neural tissue.  
The discussion of future experimentation addresses possible avenues for 
maintaining single neuron recordings for longer periods of time via application of coating 
to the surface of the microelectrode. These coatings work to decrease the adverse 
consequences of both effects of microelectrode insertion.  
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9. LIMITATIONS 
Intensity Analysis 
 
The utilization of line intensity analysis addresses many of the shortcomings of 
other methods in quantifying astrocytic up-regulation. However, there are shortcomings 
of this method that should be addressed as well. These shortcomings involved the 
variations of intensity between different days of staining and image capture. Therefore, 
with different background intensity on different days, cross comparison of the different 
groups of images may be hindered. In an attempt to minimize the effects of this, strict 
controls were maintained during tissue treatment, processing, and image capture to assure 
smallest possible deviations in background intensity. 
Also, as the electrode track is roughly circular, the use of horizontal lines do not 
actually yield the true radial distance from the edge of the track. There would be no 
feasible way to implement the use of radial intensity lines in an automated fashion with 
our software and therefore it may be prohibitively difficult to fix. However, the division 
of the image into four quadrants minimizes some of the curvature of the electrode hole 
(as compared to having the entire hole in one image) and this should mitigate the small 
difference between the horizontal and radial distance.  
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Use of Mock Microelectrode Tips 
 
 Due to the prohibitively high cost of the manufacturing of microelectrodes, 
experimentation was completed with relatively thick porous silicon wafers (100 µm) 
diced into shafts, 100 µm wide, to produce a device of 100 µm square. While we expect 
our final device to be less than 50 µm in diameter, previous work has suggested that 
1devices up to 500 µm do not increase the thickness of the glial scar, we felt confident in 
initial testing of these larger devices in vivo.  
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10. FUTURE WORK 
 
Better Understanding of Chronic Time Points 
 
Due to the anomalous data obtained at two weeks post insertion, further 
experimentation should analyze the cellular reaction to microelectrode insertion during 
this time frame. Additionally, further experimentation should be completed to analyze the 
activity of neurons and macrophages at the longer time points of two, four, and six 
weeks. If success is seen at these time points, electrically viable microelectrodes should 
be implanted for longer periods of time on the order of months. These experiments will 
be able to combine the methods utilized in this paper to quantify the cellular response 
with loss of ability to record single unit action potentials in vivo.    
 
Novel Surface Treatments 
 
Future studies should also be completed to determine appropriate surface 
treatments to augment microelectrode biocompatibility. Many groups have completed 
experimentation showing improved biocompatibility from novel surface treatments. 
Additionally, the porous surface of our microelectrode may allow for a higher volume of 
surface treatment to be coating onto the microelectrode as these coating may move into 
the porous when applied via natural capillary action or other techniques.  
Future studies, stimulated by previous work from this lab, could analyze the 
efficacy of novel surface coatings to improve the biocompatibility of porous 
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microelectrodes in the brain.  Poloxamer is one proposed novel surface treatment that has 
been utilized in the related field of traumatic brain injury to mitigate the effects of 
trauma. Currently, a study is underway to determine the effects of coating the 
microelectrode with Poloxamer 188 prior to insertion. At two, four, and six weeks post 
insertion, histology will be completed to determine the effects of this surface treatment on 
porous surfaces to increase neuronal survival and decrease glial up-regulation and 
macrophage/microglia recruitment.   
In one pilot study completed, we used laminin to coat the tips of the 
microelectrodes in order to make the relatively smooth and biologically foreign silicon 
more adapted to the brain environment. A laminin coating was used on half of the 
microelectrodes implanted, compared to saline control. Laminin was chosen because, 
although it is not present in the healthy brain tissue, it is an important aspect of the 
extracellular matrix in other body tissues and has been shown to be useful in cellular 
culture of neurons. To apply the laminin coating to the microelectrode, the 
microelectrode tips were soaked in a 10% laminin dilution in PBS overnight under an 
ultraviolet sterile hood. Application of this technique to a porous microelectrode treated 
may have the potential to further improve biocompatibility.  
Additionally, Brain Derived Neurotropic Factor (BDNF) has been studied in pilot 
work in this lab to improve the biocompatibility of porous microelectrodes in the brain. 
BDNF is a naturally occurring brain hormone involved in differentiation of brain cell 
types and healthy cellular growth in the healthy brain. BDNF is also utilized in cell 
culture to force differentiation of neural progenitors into a variety of neuronal cell types. 
To apply the BDNF coating to the microelectrode, microelectrode tips were soaked in 
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1:100 dilution of BDNF in PBS for two hours prior to insertion under an ultraviolet 
sterile hood. Application of this technique to a porous microelectrode may have the 
potential to further improve biocompatibility. 
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11. CONCLUSION 
Knowledge of both the effects of microelectrode insertion and the foreign body 
response does not immediately lead us to a solution for implantation of the 
microelectrodes. While some of the factors that contribute to this scar (size of the device 
inserted, speed of insertion, etc.) and mechanisms of scar formation (recruitment of 
macrophages, activation of microglia, etc.) have been well studied, the relationship 
between single neuron recording and glial scar formation are less well understood. We 
hypothesize that these two effects (electrode insertion and foreign body response) interact 
such that despite the fact the loss of recordings occurs months after implantation, 
processes initiated during the early phase of the response persist and contribute to the 
eventual encapsulation of the microelectrode. This idea is supported by studies on 
traumatic brain injury, demonstrating that mechanical trauma can initiate progressive 
degeneration, which continues long after the traumatic event. We expect that using a 
bioactive surface (nanostructured porous silicon), possibly in conjunction with novel 
surface coatings that help ameliorate damage to neurons due to the microelectrode 
insertion, will ultimately allow for a device that can maintain close contact of neurons to 
the recording sites and allow for very long term neuronal recordings.   
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